Patents by Inventor Kerry LAING

Kerry LAING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPITOPES CROSS-REACTIVE BETWEEN HSV-1, HSV-2 AND VZV AND METHODS FOR USING SAME
    Publication number: 20170049881
    Abstract: The invention provides epitopes of HSV and VZV that are cross-reactive and are useful for the prevention and treatment of alphaherpesvirus infection. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against whole virus. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing epitopes or polynucleotides encoding epitopes of the invention provide effectively targeted vaccines for prevention and treatment of alphaherpesvirus infection.
    Type: Application
    Filed: May 1, 2015
    Publication date: February 23, 2017
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: David M. KOELLE, Lichen JING, Kerry LAING, Christine JOHNSTON, Anna WALD